Table 1: Salient clinical characteristics of the 14 infants.

Patient Gender Age (month) Localisation Size (cm) FR Nb T I (week) FU (month) AE Cutoff F Fl Nb P Add T 1 F 3.5 Scalp and foot 1.5 N 4 2 10 Cr 550–590 30–51 2–6 N 2 F 3.5 Neck 5 P, Bl 3 2–4 10 N 550 26–30 10–15 Oral CS 3 F 3 Cheek NS N 4 2-3 30 N 590 42 3 N 4 F 7.5 Chin 2.5 N 5 4–16 24 N 590 26–42 2–6 N 5 F 7.5 Back NS N 4 3-4 66 Bl, Ulc 590 30–51 4–8 N 6 M 1.7 Thigh and forearm NS N 3 1-2 2.3 Cr 590 46 10–14 N 7 F 2.8 Forehead 0.8 N 1 3 N 590 45 1 N 8 M 5 Cheek, forearm, back, and scalp NS N 3 3 11 N 590 45–48 3–5 N 9 M 2.5 Ear meatus 3.5 N 1 5.6 N 590 44 4 N 10 F 1.4 Scalp 1.5 N 3 2–12 3.5 N 590 45 3 N 11 F 8 Eyebrow NS N 4 4–8 16 N 550 26–38 2 N 12 M 5 Nose NS Bl 1 5 N 550 28 3 N 13 F 3.5 NS NS N 6 4–8 10.5 N 550–590 36–51 1 N 14 M 12 Back and hand NS N 2 52 24 N 550 26–32 1–3 N

Age = at first visit; FR = functional repercussion (at the time patient was seen) Nb T, I = number of treatments, interval; FU = followup (= last seen at the age mentioned); AE = adverse events cutoff F, Fl, Nb P = cutoff filters (nm), fluence (J/cm²), number of pulses per treatment; Add T = additional treatment F = female; M = male; N = none; NS = not specified, C = clearance P = pain; Bl = bleeding; Ulc = ulceration; Tel = telangiectasias; Cr = crusts CS = corticosteroids.